Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Vertex Pharmaceutic (NASDAQ: VRTX)

$116.70 USD -$0.56 (-0.48%)
Last Price $116.7
Net Change $-0.56 (-0.48%)
Bid $0
Ask Price $0
Open Price $117.17
Previous Close Price $117.26
High Price $117.69
Low Price $115.92
Number of Trades 7,230
Volume 2,803,900
Fifty Two Week High $117.99 (2017-04-20)
Fifty Two Week Low $71.46 (2016-12-22)
Average Daily Volume 1,900,328
Share Outstanding 249,040 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $0.35 (2017-01-25)
2nd Quarter Earnings $0.16 (2016-10-25)
3nd Quarter Earnings $0.24 (2016-07-27)
4th Quarter Earnings $0.09 (2016-04-27)
PE Ratio $0
EPS Growth $559.09
Recent Earnings $0.35
Annual EPS $-0.1
Last Quarter EPS $
Market Capitalization $29.06B
Insider Shareholders % 0.019%
Annual Revenue $0B
No. Shares Outstanding 249,040
Inst. Shareholder % 94.96%
Annual Net Income $0B
TTM Net Profit Margin $115.81
1-Year Return 34.45%
3-Year Return 74.39%
5-Year Return 218.24%
5-Year Revenue Growth 20.67%
5-Year Earnings Growth -77.55%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 559.090027%
Dividends per Share $
Stock Split Ratio 2-1
Beta 0.75
Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)